Login Form

Please log in to gain access to the full suite of EUROCORD-ED educational resources for members.


Webcasts

Note: to view these webcasts you need to be a registered user

World Cord Blood Congress III, Roma, Italy, October 2011

ESH - EBMT Training Course Blood and Marrow Transplantation, La Baule, France, May 2011

ESTM Cord Blood Banking Conference, Pescara, Italy, November 2009

ESH-EBMT Training Course, Latimer, UK, May 2009

ESH-Eurocord-Netcord Cord Blood Conference, Mandelieu, France, October 2008


Social media


Follow us on

Subscribe to news alert

Enter your email address:

Delivered by FeedBurner

This website is certified by Health  On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

EUROCORD-ED is the European Online Cord Blood Learning Portal for use by Doctors, Nurses, Midwives, Surgeons, UCB Processing & Testing Laboratories, Scientists and Study Groups.

Eurocord-Ed Eurocord-Ed
Upcoming Events

ESH-iCMLf International Conference CHRONIC MYELOID LEUKEMIA: Biology and Therapy

September 20 - September 23, 2012 - Baltimore, U S A
Chairs : J.M. Goldman, Jorge Cortes, T.P. Hughes

Speakers at this meeting will present the newest and often unpublished data that relate to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) Aspects of treatment including prediction and definition of responses, drugs used in combination, molecular monitoring, targeting residual stem cells and approaches to cure.
Direct link

ESH International Conference on Myeloproliferative Neoplasms

October 04 - October 06, 2012 - Vienna, Austria
Chairs : A. R. Green, H. L. Pahl, R. Skoda, T. Barbui , W Vainchenker

Over the past few years there has continued to be a flood of new insights into the classification, pathogenesis and management of the myeloproliferative neoplasms. This event is essentially a workshop with an audience. It brings together scientists and clinicians with new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment

Direct link

ESH International Conference on Lymphomas

October 28 - October 30, 2012 - Marseille, France
Chairs : Angelo Michele Carella, Bertrand Coiffier, Peter Johnson

Our knowledge on the pathology of lymphoma and on the therapeutic possibilities has greatly changed during the last 10 years. Lymphoma is a complex cancer with several entities, each with its own genetic abnormalities, spreading characteristics, and therapeutic options.

Numerous pathways controlling important cellular mechanisms have been found to be deregulated in lymphoma cells, leading to cell growth or refractoriness to therapy. Inhibitors specific for these different pathways are gaining therapeutic roles.



Direct link

EMTACT 2012 - HIGHLY SPECIALISED KNOWLEDGE
modified 2012-05-07 by Nancy Hamilton

As you know, EMTACT has been posponed until October.
Please find the revised programme in .pdf.

PDF


Observatory of Sickle Cell Disease to open in Monaco
modified 2012-05-04 by Nancy Hamilton




Twenty-five experts gathered in Monaco for the first meeting to set up an observatory of sickle cell disease. The disease, which affects the haemoglobin of thousands of newborn children each year, has become a major public health problem both in Europe and more widely in Africa where the disease affects many people.

The "Centre Scientifique de Monaco" will host the observatory as of January 1, 2013 with the aim to establish a working group on the management and treatment of sickle cell disease.

According to Professsor Eliane Gluckman, "We must promote exchange between countries and then to adapt techniques and treatment of sickle cell disease." The mission of the observatory will be to coordinate programmes, to adapt resources to disseminate knowledge, and share expertise. The observatory will support research on stem cells from umbilical cord, which is one of the keys in the treatment of sickle cell disease.